A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors
PLOS Computational Biology · 04.11.2024 · 20 (11) · e1012552
DOI: 10.1371/journal.pcbi.1012552 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 04.11.2024. Verfasst von Alireza Rezvani-Sharif und 6 weiteren Autor:innen. Beteiligte Einrichtung: CSL Ltd, Bio21 Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Kallikrein-Kinin System, Bradykinin, Models, Biological. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The kallikrein-kinin system (KKS) is a complex biochemical pathway that plays a crucial role in regulating several physiological processes, including inflammation, coagulation, and blood pressure. Dysregulation of the KKS has been associated with several pathological conditions such as hereditary angioedema (HAE), hypertension, and stroke. Developing an accurate quantitative model of the KKS may provide a better understanding of its role in health and disease and facilitate the rapid and targeted development of effective therapies for KKS-related disorders.
Objectives
Here, we present a novel, detailed mechanistic model of the plasma KKS, elucidating the processes of Factor XII (FXII) activation, the kallikrein feedback loop, cleavage of high molecular weight kininogen leading to bradykinin (BK) production, and the impact of inhibitors.
Methods
The model incorporates both surface and solution-phase reactions of all proteins in the KKS, describing how binding site concentration affects the rate of surface reactions. The model was calibrated and validated using a variety of published and in-house experimental datasets, which encompass a range of dextran sulphate (DXS) concentrations to initiate contact activation and various KKS inhibitors to block bradykinin production.
Results
Our mathematical model showed that a trace amount of activated FXII is required for subsequent FXII activation. The model also reveals a bell-shaped curve relationship between the activation of the KKS and the number of DXS surface binding sites. Simulations of BK generation in healthy and HAE plasma demonstrated the impact of C1 esterase inhibitor (C1inh) deficiency via increased peak BK levels and accelerated formation in HAE plasma. The efficacy of KKS inhibitors, such as CSL312, ecallantide, and C1inh, was also evaluated, with CSL312 showing the most potent inhibition of BK generation.
Conclusions
The present model represents a valuable framework for studying the intricate interactions within the plasma KKS and provides a better understanding of the mechanism of action of various KKS-targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CSL Ltd, Bio21 Institute, Melbourne, Victoria, Australia.
- Department of Chemical Engineering, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Alireza Rezvani-Sharif, Ineke L Muir
Zitieren
APA
Rezvani-Sharif, A., Lioe, H., Dower, S. K., Pelzing, M., Panousis, C., Harvie, D. J. E., & Muir, I. L. (2024). A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors. PLOS Computational Biology, 20(11), e1012552. https://doi.org/10.1371/journal.pcbi.1012552
Vancouver
Rezvani-Sharif A, Lioe H, Dower SK, Pelzing M, Panousis C, Harvie DJE, et al. A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors. PLOS Computational Biology. 2024;20(11):e1012552. doi:10.1371/journal.pcbi.1012552
BibTeX
@article{RezvaniSharif2024,
author = {Rezvani-Sharif, Alireza and Lioe, Hadi and Dower, Steven K and Pelzing, Matthias and Panousis, Con and Harvie, Dalton J E and Muir, Ineke L},
title = {A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors},
journal = {PLOS Computational Biology},
year = {2024},
volume = {20},
number = {11},
pages = {e1012552},
doi = {10.1371/journal.pcbi.1012552}
}
EUVIMED